Barclays PLC Grows Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Barclays PLC grew its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 3.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,690,279 shares of the company's stock after purchasing an additional 48,536 shares during the period. Barclays PLC owned about 0.65% of Ryan Specialty worth $108,449,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Rakuten Securities Inc. bought a new stake in shares of Ryan Specialty during the fourth quarter worth $27,000. Principal Securities Inc. increased its holdings in Ryan Specialty by 164.7% during the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock worth $43,000 after buying an additional 415 shares during the last quarter. Mizuho Bank Ltd. bought a new stake in Ryan Specialty during the fourth quarter worth $49,000. Headlands Technologies LLC increased its stake in shares of Ryan Specialty by 2,644.8% during the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after purchasing an additional 767 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new position in shares of Ryan Specialty during the 4th quarter worth approximately $54,000. Institutional investors own 84.82% of the company's stock.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 10,485 shares of the company's stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total transaction of $682,783.20. Following the completion of the sale, the director now directly owns 11,109 shares in the company, valued at $723,418.08. This represents a 48.56 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company's stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 141,894 shares of company stock valued at $9,429,470. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Stock Down 2.0 %

Shares of NYSE:RYAN traded down $1.46 during mid-day trading on Friday, hitting $70.63. 967,494 shares of the company traded hands, compared to its average volume of 943,985. The stock has a market cap of $18.50 billion, a P/E ratio of 102.37, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a 50-day moving average price of $70.46 and a two-hundred day moving average price of $69.03. Ryan Specialty Holdings, Inc. has a 12-month low of $48.48 and a 12-month high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a dividend of $0.12 per share. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's payout ratio is 69.57%.

Analyst Upgrades and Downgrades

RYAN has been the topic of several research analyst reports. TD Cowen started coverage on shares of Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target on the stock. Barclays cut their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Royal Bank of Canada reduced their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Finally, Wells Fargo & Company reduced their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Ryan Specialty currently has a consensus rating of "Hold" and a consensus target price of $75.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.